Supplemental material
Leukemia & Lymphoma
Volume 61, 2020 - Issue 3
Open access
2,288
Views
3
CrossRef citations to date
0
Altmetric
Letters to the Editor
Clinical outcomes with fixed-duration therapy (UK real-world data) compared with continuous lenalidomide and low-dose dexamethasone therapy (FIRST trial; MM-020) for transplant-ineligible patients with newly-diagnosed multiple myeloma
Faye A. SharpleyDepartment of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; View further author information
, Faouzi DjebbariDepartment of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; http://orcid.org/0000-0001-9578-7632View further author information
, Samih FouraliDepartment of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; View further author information
, Jaimal KothariDepartment of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; ;NIHR Oxford Biomedical Research Centre Blood Theme, Oxford, UK; View further author information
, John A. LynesCelgene Ltd, Uxbridge, UK; View further author information
, Susan McLain-SmithpH Associates Ltd, Marlow, UKView further author information
& Karthik RamasamyDepartment of Clinical Haematology, Oxford University Hospitals NHS Foundation Trust, Oxford, UK; ;NIHR Oxford Biomedical Research Centre Blood Theme, Oxford, UK; Correspondence[email protected]
http://orcid.org/0000-0003-3385-3707View further author information
show allhttp://orcid.org/0000-0003-3385-3707View further author information
Pages 732-736
|
Received 22 Jul 2019, Accepted 14 Oct 2019, Published online: 27 Nov 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.